Acer Therapeutics Inc (NASDAQ:ACER)

3.67
Delayed Data
As of Dec 06
 +0.09 / +2.51%
Today’s Change
1.87
Today|||52-Week Range
28.25
-81.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues2.6M2.9M0.000.00
 
 
 
Depreciation And Amortization351.4K238.1K4.0K27.7K
 
 
 
 
 
 
Operating ExpensesGross Income-----4.0K-27.7K
 
 
 
General Expenses14.3M9.6M13.9M21.7M
 
 
 
 
 
Research And Development10.0M6.5M8.7M12.5M
 
 
 
 
 
Total Operating Expenses14.6M9.9M13.9M21.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.1M-7.0M-13.9M-21.7M
 
 
 
 
 
Extraordinary Charge0.00-1.0M0.000.00
 
 
Interest Expense On Debt2.3K3.3K245.1K987.00
 
 
 
 
 
Other Expenses67.5K8.3K-16.1K20.6K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.0M-8.0M-14.2M-21.3M
 
 
 
 
 
Net Income-12.0M-8.0M-14.2M-21.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS----3.7M8.6M
 
 
 
Shares To Calculate EPS Diluted----3.7M8.6M
 
 
 
 
Earnings Per ShareEPS-----$3.84-$2.49
 
 
 
EPS Diluted-----$3.84-$2.49